BRENDA SANTOS: Open Payments
NPI 1255660916 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 68 payments from 16 companies in 2025. Trend: 2023 $1,131 · 2024 $1,452 · 2025 $1,557
Food & beverage: $1,557
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $290 |
| Novo Nordisk Inc | 14 | $244 |
| AstraZeneca Pharmaceuticals LP | 4 | $215 |
| Corcym Inc | 1 | $211 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $131 |
| Exact Sciences Corporation | 7 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| TOLMAR, INC. | 3 | $64 |
| Insulet Corporation | 3 | $62 |
| Lilly USA, LLC | 2 | $34 |
Products named: PERCEVAL, Kerendia, UBRELVY, Rybelsus, Ozempic, VRAYLAR, QULIPTA, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
